BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 25724817)

  • 1. Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases?
    Scichilone N; Benfante A; Bocchino M; Braido F; Paggiaro P; Papi A; Santus P; Sanduzzi A
    Pulm Pharmacol Ther; 2015 Apr; 31():63-7. PubMed ID: 25724817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novolizer: how does it fit into inhalation therapy?
    Magnussen H
    Curr Med Res Opin; 2005; 21 Suppl 4():S39-46; discussion S47. PubMed ID: 16138944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD].
    Henriet AC; Marchand-Adam S; Mankikian J; Diot P
    Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of inhaler devices in the management of airway disease.
    Virchow JC; Crompton GK; Dal Negro R; Pedersen S; Magnan A; Seidenberg J; Barnes PJ
    Respir Med; 2008 Jan; 102(1):10-9. PubMed ID: 17923402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Evolution of Pressurized Metered-Dose Inhalers from Early to Modern Devices.
    Roche N; Dekhuijzen PN
    J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):311-27. PubMed ID: 26824873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asthma and chronic obstructive pulmonary disease inhalers: Techniques for proper use.
    Pepper AN; Cooke A; Livingston L; Lockey RF
    Allergy Asthma Proc; 2016 Jul; 37(4):279-90. PubMed ID: 27401315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demystifying Dry Powder Inhaler Resistance with Relevance to Optimal Patient Care.
    Capstick TGD; Gudimetla S; Harris DS; Malone R; Usmani OS
    Clin Drug Investig; 2024 Feb; 44(2):109-114. PubMed ID: 38198116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
    Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A narrative review on the Synchrobreathe™: A novel breath-actuated pressurised metered-dose inhaler for the treatment of obstructive airway diseases.
    Lavorini F; Usmani OS; Salvi S; Rote K; Gaur V; Gogtay J
    Respir Med; 2023; 219():107435. PubMed ID: 38652077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhalatory therapy training: a priority challenge for the physician.
    Melani AS
    Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of co-milling techniques for the production of high dose dry powder inhaler formulation.
    Lau M; Young PM; Traini D
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1229-1238. PubMed ID: 28367654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing drug delivery in COPD: The role of inhaler devices.
    Rogliani P; Calzetta L; Coppola A; Cavalli F; Ora J; Puxeddu E; Matera MG; Cazzola M
    Respir Med; 2017 Mar; 124():6-14. PubMed ID: 28284323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhalation therapy in asthmatic and not asthmatic children.
    Lo Valvo L; Leonardi S; Marseglia GL; Miraglia Del Giudice M; Salpietro C; Ciprandi G; La Rosa M
    Int J Immunopathol Pharmacol; 2011 Oct; 24(4 Suppl):61-7. PubMed ID: 22032789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the use of dry powder inhalers in situations perceived as constrained.
    Borgström L
    J Aerosol Med; 2001; 14(3):281-7. PubMed ID: 11693839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler.
    Sorino C; Negri S; Spanevello A; Visca D; Scichilone N
    Eur J Intern Med; 2020 May; 75():15-18. PubMed ID: 32113944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled drug delivery in the hands of the patient.
    Lavorini F
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):414-8. PubMed ID: 25238005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misuse and/or treatment delivery failure of inhalers among patients with asthma or COPD: A review and recommendations for the conduct of future research.
    Mahon J; Fitzgerald A; Glanville J; Dekhuijzen R; Glatte J; Glanemann S; Torvinen S
    Respir Med; 2017 Aug; 129():98-116. PubMed ID: 28732842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What plays a role in the choice of inhaler device for asthma therapy?
    Virchow JC
    Curr Med Res Opin; 2005; 21 Suppl 4():S19-25. PubMed ID: 16138941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhalers and inhalation techniques in the treatment of asthma and chronic obstructive pulmonary disease].
    Fuglø-Mortensen R; Lange P; Mortensen J
    Ugeskr Laeger; 2019 Aug; 181(33):. PubMed ID: 31495355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.